Microcirculatory rheology and blood cell aggregation state

Microcirculatory rheology and blood cell aggregation state refer to the complex physical properties and flow characteristics of blood within the microvascular bed, including capillaries and small vessels. This state is primarily determined by plasma viscosity, hematocrit, and the mechanical behavior of red blood cells, specifically their deformability and tendency to form aggregates or "rouleaux" (Baskurt & Meiselman, 2003, "Blood Rheology and Hemodynamics"). In clinical contexts, impaired rheology is a hallmark of diseases such as diabetes mellitus, sickle cell anemia, and peripheral artery disease, where increased blood viscosity and cell rigidity lead to microvascular occlusion and tissue ischemia (Popel & Johnson, 2005, "Microcirculation and Hemorheology"). Although not a discrete molecular target like a receptor or enzyme, these rheological parameters are modulated by various therapeutic agents to improve systemic and local perfusion. For instance, pentoxifylline is utilized to enhance erythrocyte flexibility, while hydroxyurea is employed in sickle cell disease to alter cell composition and reduce aggregation (StatPearls, "Pentoxifylline"; NIH, "Sickle Cell Disease"). Understanding and monitoring these states through biomarkers like plasma viscosity and erythrocyte sedimentation rate is crucial for assessing vascular health and treatment efficacy.

Other names

HemorheologyBlood viscosityErythrocyte aggregationMicrovascular blood flowRed blood cell aggregation

Pharmacological agents modulate microcirculatory rheology by reducing plasma viscosity, enhancing red blood cell deformability, or inhibiting cellular aggregation, thereby decreasing vascular resistance and improving tissue perfusion.